Loading clinical trials...
Loading clinical trials...
A Phase 1, Open-Label, Single-Dose, Non-Randomized Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Betrixaban in Pediatric Patients
Conditions
Interventions
Betrixaban
Locations
20
United States
Children's Hospital Los Angeles
Los Angeles, California, United States
ACTCA, Axis Clinical Trials
Los Angeles, California, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Tulane Medical Center
New Orleans, Louisiana, United States
Rainbow Babies & Children's Hospital
Cleveland, Ohio, United States
Children's Hospital of Tatarstan Republic
Kazan', Russia
Start Date
July 13, 2018
Primary Completion Date
October 8, 2019
Completion Date
October 8, 2019
Last Updated
January 12, 2024
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions